Jin Yang Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	50,027	64,938	66,504	66,805	70,257	78,689
Market Cap Growth	-32.03%	-2.35%	-0.45%	-4.91%	-10.72%	0.57%
Enterprise Value	120,338	137,575	148,150	73,349	78,626	79,706
Last Close Price	3875.00	5030.00	5652.12	5859.13	6021.93	6356.42
PE Ratio	2.26	2.91	2.24	5.41	5.71	8.25
PS Ratio	0.41	0.54	0.59	0.71	0.92	1.25
PB Ratio	0.31	0.41	0.56	0.75	0.91	1.21
P/TBV Ratio	0.32	0.42	0.58	0.80	0.95	1.24
P/FCF Ratio	-	-	-	8.51	16.61	-
P/OCF Ratio	14.87	44.33	5.20	7.83	9.43	39.93
EV/Sales Ratio	0.99	1.14	1.31	0.78	1.03	1.27
EV/EBITDA Ratio	26.79	27.88	10.79	6.47	5.86	8.74
EV/EBIT Ratio	58.69	54.46	12.65	8.45	7.06	11.45
EV/FCF Ratio	-	-	-	9.34	18.59	-
Debt / Equity Ratio	0.48	0.48	0.67	0.09	0.26	0.31
Debt / EBITDA Ratio	17.00	15.55	5.80	0.69	1.49	2.20
Debt / FCF Ratio	-	-	-	1.00	4.72	-
Net Debt / Equity Ratio	0.44	0.44	0.65	-0.01	0.12	0.08
Net Debt / EBITDA Ratio	15.65	14.36	5.66	-0.07	0.71	0.56
Net Debt / FCF Ratio	-28.67	-25.30	-1.00	-0.10	2.24	-9.41
Asset Turnover	0.49	0.49	0.65	0.80	0.72	0.74
Inventory Turnover	2.86	2.81	2.72	2.24	2.50	3.41
Quick Ratio	0.34	0.33	1.44	1.24	0.98	1.16
Current Ratio	0.52	0.52	2.19	1.96	1.50	1.51
Return on Equity (ROE)	15.74%	15.93%	28.46%	14.84%	17.23%	16.79%
Return on Assets (ROA)	0.51%	0.64%	4.21%	4.63%	6.54%	5.12%
Return on Invested Capital (ROIC)	0.70%	0.94%	6.57%	9.92%	11.98%	9.16%
Return on Capital Employed (ROCE)	1.10%	1.40%	5.60%	9.10%	13.30%	9.80%
Earnings Yield	44.55%	34.32%	44.65%	18.47%	17.52%	12.12%
FCF Yield	-4.90%	-4.31%	-116.19%	11.75%	6.02%	-0.69%
Payout Ratio	7.69%	7.69%	5.45%	13.10%	9.08%	11.72%
Buyback Yield / Dilution	-8.95%	-1.00%	1.17%	7.18%	-17.77%	-2.12%